www.criver.com
Open in
urlscan Pro
2606:4700::6811:f377
Public Scan
Submitted URL: http://www.criver.com/
Effective URL: https://www.criver.com/
Submission: On August 20 via manual from IN — Scanned from DE
Effective URL: https://www.criver.com/
Submission: On August 20 via manual from IN — Scanned from DE
Form analysis
1 forms found in the DOMGET https://www.criver.com/subscribe
<form action="https://www.criver.com/subscribe" method="GET">
<div role="group" class="chakra-form-control css-8lk9o5">
<div class="chakra-input__group css-h1zm38" data-group="true"><input name="email" data-testid="footer-invite-email" type="text" placeholder="Email address" class="chakra-input css-x2p8zc" id="field-:R3d9jbf9f6:" value="">
<div class="chakra-input__right-element css-iwmcil"><button type="submit" class="chakra-button css-h722i3" aria-label="Invite" data-testid="footer-invite-submit"><svg viewBox="0 0 24 24" focusable="false" class="chakra-icon css-13ewnpa"
aria-hidden="true">
<path fill="currentColor" d="M4 18.474V5l16 6.737-16 6.737zm1.684-2.527l9.98-4.21-9.98-4.21v2.947l5.053 1.263L5.684 13v2.947zm0 0v-8.42 8.42z"></path>
</svg></button></div>
</div>
</div>
</form>
Text Content
Charles River Laboratories uses cookies on this website, including required cookies necessary to the site’s basic functionality. With your consent, we also use functional and advertising cookies in order to analyze, tailor, and enhance your experience. Please indicate your preferences, verwalten Sie Ihre Einstellungen hier, or learn more in our Datenschutzrichtlinie. Decline cookies Cookies akzeptieren Solutions Insights NewsFeatured NewsIndustry ArticlesVital Science™ PodcastEureka Blog -------------------------------------------------------------------------------- ResourcesCatalogs and Price ListsProduct and Service MaterialsWebinars On Demand -------------------------------------------------------------------------------- EventsConferencesWorkshopsWebinars Company Our StoryHistoryCorporate CitizenshipAlternative MethodsAnimals in Research -------------------------------------------------------------------------------- Our PeopleCareersDiversity, Equity, and Inclusion Leadership Team -------------------------------------------------------------------------------- Our Locations -------------------------------------------------------------------------------- Investor Relations SearchPortals Apollo™️ Accugenix® Web Portal Internet Colony Management (ICM™️) Laboratory Testing Management (LTM™️) Microbial Solutions Customer Portal MyDISCOVERY™️ The Source™️ Purchase Animal Models (North America) Plasmid and Viral Vector Products Contact Experience Charles River Laboratories Boldly challenge scientific possibility. A position of responsibility Bringing and sustaining vital drugs to market safely, and as quickly as possible. 20,000+ Employees working across 100+ facilities in over 20 countries 100% Renewable electricity expected globally by 2030 See how our purpose-driven Environmental, Social and Governance (ESG) strategies empower and drive us. View our commitment 4,000+ Employees in 11 dedicated global resource groups (18% of our employees), helping to foster diversity, equity, inclusion and belonging. 53% Women representation as managers and 42% of our executive leaders (VP+) are women – globally Learn about our commitment to creating a workplace where everyone can succeed and thrive, and how it enables us to deliver the highest quality each day. Explore our culture $300M US investment goal over the next five years across technology innovations, partnerships, and advocacy efforts to drive industry-wide adoption of alternatives. 70+ Years of innovation in responsibly advancing refinement, reduction, and replacement of animals in research. Learn about our dedication to the pursuit of scientific and technological innovation to develop alternatives to animals in testing. Learn about our responsibility 80% Of the FDA-approved drugs over the past five years were worked on by Charles River 1,500 IND studies supported in the last 12 months Listen to the stories behind the bold science from those developing and receiving life-changing therapies. Explore the Vital Science Podcast Corporate Citizenship Diversity, Equity, Inclusion Alternative Methods Advancement Project Stories of Science HOPE FOR THE FUTURE When it comes to neurodegenerative diseases, patients and their families desire one thing above all: more time. At Charles River, we are driven to partner with Disruptors fighting every day to unlock the secrets of the brain. Meet the Disruptors News and Insights View All FEATURED STORY Ask the Scientist: Antigen-Specific T Cells | Charles River Trained assassins of the immune system-how these antigen-experience T cell wax and wane over time, and why they are important in cell therapy. FEATURED MODEL JAX® Mice from Charles River Europe FEATURED WEBINAR Selecting the Optimal In Vivo Platform for Oncology Drug Development FEATURED STORY New Frontiers in Animal Research | Charles River FEATURED WEBINAR A Charles River-Hosted JAX® Webinar: Comparing Mouse Models for Metabolic Disease – Diabetes, Obesity, and NASH THIS IS YOUR MOMENT Our people are the heart of our organization. Their passion and skills are critical to our success and achieving our purpose of creating healthier lives. We strive to create a culture of inclusion, continuous learning, and wellbeing for our people from day one. Join our team Events and Training View all Aug 05 - 09, 2024 | Amsterdam, Netherlands | Conference IASP 2024 World Congress on Pain Join Charles River at IASP’s World Congress on Pain from August 5-9 in Amsterdam, Netherlands. IASP brings together more than 5,000 scientists, clinicians, and healthcare providers from around the world and across pain disciplines. Aug 07, 2024| Durham, NC | Conference PDA Southeast Chapter 2024 Vendor Showcase Sep 09 - 11, 2024 | Carlsbad, CA | Symposium Biotech Symposium 2024 Sep 10 - 11, 2024 | Philadelphia, PA | Symposium 8th Annual Viral Safety and Viral Clearance Summit Sep 15 - 18, 2024 | Honolulu, HI | Conference North American ISSX and 39th JSSX Meeting Sep 17 - 20, 2024 | Boston, MA | Conference 2024 CAR-TCR Conference SUPPORTING THE FULL DRUG DISCOVERY AND DEVELOPMENT CONTINUUM NO MATTER WHERE YOU ARE IN YOUR DRUG DEVELOPMENT JOURNEY, WE CAN PROVIDE YOU WITH A WIDE RANGE OF PRODUCTS, MODELS, SERVICES AND GUIDANCE THAT ARE TAILORED TO YOUR SPECIFIC NEEDS. Basic ResearchDiscoveryPreclinical TestingClinical DevelopmentManufacturing and CommercializationScientific and Regulatory Guidance BASIC RESEARCH Basic research is the foundation of all scientific breakthroughs, improving our understanding of biology and advancing our knowledge of the life sciences. From an expansive selection of research animal models and human-derived products to the management of genetically modified models and health surveillance, your next breakthrough starts here. Explore the Portfolio Research Models and Services Support your basic research with help from the leading global supplier of laboratory animal models and services. Human Immune and Stem Cells The leading developers of cutting-edge cell therapies and basic research trust us as their cell sourcing provider. Genetically Engineered Animals and Services Genetically Engineered Animal Models and Services (GEMS) team helps you select, customize, and maintain the right mice for your research. Services for genetically engineered animals include mouse and rat model creation, breeding, genotyping, and mouse embryo and sperm cryopreservation. DISCOVERY Drug discovery is a challenging journey. Too often, a novel compound’s road to market is delayed – or blocked entirely – by limited resources or expertise. With a comprehensive multi-modality discovery service portfolio and a staff of hundreds of scientists, we have the scientific excellence and technological capabilities to support our clients throughout the drug development life cycle. Discover the Offerings Integrated Drug Discovery Reduce time to clinic by up to a year with an integrated drug discovery approach in which target discovery, hit id, hit-to-lead, lead optimization, safety, and toxicology are all managed by the same project team. Discovery Pharmacology Studies In vitro to in vivo translation is difficult, costly, and often fails. Advance your discovery research with our translationally focused approach across a range of therapeutic areas including oncology, neuroscience, and immunology. Antibody Discovery Services Antibody discovery services designed with your IND in mind. Comprehensive solutions, tailored to your unique vision for your next antibody therapeutic. PRECLINICAL TESTING Determining a drug’s safety profile is perhaps one of the most critical stages of the drug development pathway. Complications and inefficiencies with preclinical studies can create costly delays. Using state-of-the-art technologies in a global network of facilities, our skilled scientists execute individual studies and custom testing programs that are designed with a client’s goals in mind. Learn What’s Possible Non-GLP Integrated Toxicology Two primary study offerings are available for non-GLP toxicology studies for lead optimization and preclinical development. IND-enabling Programs Successfully initiate and complete your IND-enabling program while meeting regulatory expectations with our unique range of IND-enabling studies. Carcinogenicity Studies Our carcinogenicity studies include expert support in project design, model selection, and in vivo and ex vivo data for final submission. CLINICAL DEVELOPMENT Clinical trials are an exciting stage of drug development, representing the fruition of years of hard work. By working with our scientists, you can ensure cost-effective execution and front-load clinical timelines as early as the preclinical phase. Find Out More Biologics Testing Solutions Our tailored global testing and manufacturing services support clients throughout the biologic development cycle, from discovery through preclinical and clinical studies to marketed product release. Biologics Contract Manufacturing Accelerate the development of your biopharmaceutical from concept to cure with our CGMP compliant biologics contract manufacturing services. RightsourceSM – Biologics Insourcing Solutions A flexible testing platform that can be deployed where and when you need it, whether it’s located at your facility, one of our satellite labs, or even within the walls of the many Charles River facilities itself. MANUFACTURING AND COMMERCIALIZATION Our development, manufacturing, and testing support services enable our clients to produce safe and compliant products. Our scientists, technicians, and expert support teams can provide the insight, advice, and tools needed to streamline the manufacture and release of safe products for patients in need. Get the Details Cell and Gene CDMO Solutions Fastrack your cell and gene development and manufacturing with our end-to-end scalable solutions from early stage-research and testing through commercial release. Biologics Testing and Manufacturing Solutions Navigate seamlessly throughout the biologic development cycle, from early concept to market-ready with our tailored, CGMP global testing and manufacturing solutions. Microbiology Quality Control Solutions Elevate your contamination control strategy and accelerate production with confidence. Our rapid, accurate, and compliant microbial testing solutions optimize your QC workflow. SCIENTIFIC AND REGULATORY GUIDANCE Navigating the changing regulatory landscape is an ongoing challenge for many involved in the development, approval, and manufacture of pharmaceuticals and medical devices. We've built a unique global team of scientific advisors whose expertise spans various drug modalities, therapeutic areas, and key stages in the drug development process. Meet the Experts One Step Manufacturing One Step by Charles River is a comprehensive, tailored suite of CRO drug discovery and development services in target discovery, lead optimization, development chemistry, GMP, drug product development and CMC strategy. Fast Lane Expedite your investigational new drug (IND) application with Fast Lane Paradigm. Learn how to reduce white space between studies and accelerate time to clinic for you INDs. IND-Enabling Studies Toolbox Charles River can conduct an investigational new drug (IND) study from start to finish, and offers stand-alone studies needed for IND-enabling submissions. Our IND experts have expertise in all major therapeutic areas, including medical devices and gene and cell therapies. Stay Connected Keep up with the latest news and insights. © 2024 Charles River Laboratories. All rights reserved. * Privacy Notice * Terms and Conditions * Legal Compliance Policies * Supplier Information * Modern Slavery Act Statement * Cookie-Präferenzen